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Sensitivity to Meropenem
Conclusion: The use of Levolfoxacin as a prophylactic agent
had not resulted in a statistically signiﬁcant increase of resistance
among the common Gram negative pathogens. However, close
monitoring is warranted as a trend towards increase in the pro-
portion of resistance was noted.
http://dx.doi.org/10.1016/j.ijid.2016.02.222
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Background: Despite the availability of potent new anti-
microbial agents and vaccines, Community Acquired Pneumonia
(CAP) remains a common and serious illness .The microbial etiolo-
gies and their resistant patterns vary widely. Frequent, irrational
and unnecessary use of antibiotics, changes in environment,
changes in lifestyle and increased mobility of the people have con-
tributed to changes in the patterns of microbial proﬁles and their
resistant patterns in the Community. Unfortunately, there have
been very few studies done regarding etiology of CAP, prevalence
of causative organisms and their resistance pattern in Nepal. Thus
it was quite crucial to detect them in our context
Methods & Materials: A descriptive cross-sectional study con-
ducted over a period of six months (March 2011–August 2011) at
Bacteriology laboratory of Tribhuvan University and Teaching Hos-
pial (TUTH) among 600 clinically diagnosed CAP patients visiting
TUTH-OPD. Sputum samples that met the acceptance criteria of
ASM were further processed according to the standard methodol-
ogy.
Results: Bacterial etiologies could be identiﬁed only in 25.5% of
cases of CAP. Haemophilus inﬂuenzae (26.9%), Streptococcus pneu-
moniae (20.0%) and Pseudomonas aeruginosa (19.4%) were the
commonest bacterial etiologies, Twenty-six percent ofH. inﬂuenzae
isolates were MDR The prevalence of MDR bacteria in CAP patients
was 41.25%. Among gram-negative bacterial isolates, the highest
number of MDR was seen in Pseudomonas aeruginosa, followed by
Klebsiella pneumoniae, E. coli and Acinetobacter spp.
The prevalence of ESBL, AmpC and MBL producing gram-
negative bacteria were 10.1% (more common among Klebsiella
pneumoniae (16.6%), 5.8% and 4.3% (more common among Acine-
tobacter spp(14.29%) respectively.
Conclusion: Different bacteria are responsible for CAP in our
setting. MDR, ESBL, MBL and AmpC producing bacterial strains are
present in our Community also. Thus it has demanded to take spe-
cial care during treatment of patients with community acquired
infections also and also sought for other similar type of exten-
sive studies on large number of community isolates to characterize
their genetic relatedness and resistant patterns so that appropriate
measures can be applied.
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Background: Staphylococcus aureus (S. aureus) is an important
pathogen for hospital-associated infections, and it is especially dif-
ﬁcult to treat because of emerging resistance tomany antimicrobial
drugs. Methicillin-resistant S. aureus (MRSA) have emerged as a
clinically relevant human pathogen. Intracellular destruction of
invading S. aureus is mainly mediated by phagocytosis, and this
phagocytic process is crucial to the host innate defense against
Staphylococci, so, disorders of phagocytic cells- as in cases of
leukemia- cause frequency of infections at epithelial surfaces and
the frequency of dissemination. The aim of study is to evaluate
MRSA strains isolated from leukemia patients admitted to hospitals
in regard to drug resistance.
Methods&Materials: A cross-sectional studywas conducted at
the Hematology center/Al-Mustansiriya University- Baghdad, from
November 2013 toMarch2014,where 48 known leukemia patients
aged from 15 to 81 years have been enrolled for the detection of
MRSA in their blood. Blood culture and conventionalmethodswere
used for the isolation and identiﬁcation of pathogenic bacteria,
along with the phenotypic and genotypic methods (i.e. detection
of “PBP2a”) for the identiﬁcation of MRSA. Antibiotic susceptibility
testing and vancomycin minimum inhibitory concentration (MIC)
were also performed for all S. aureus isolates.
Results: Positive blood culture resultswere detected in 34 (71%)
of patients. Among them, S. aureus was accounted for 11 (26.8%) of
isolates. Antibiotics susceptibility tests for S. aureus isolates showed
that 9 (82%) strains isolated from patients in current study were
of MRSA variety. All of the S. aureus strains (100%) in current
study were susceptible to Carbapenems. Intermediate resistance
to vancomycin was noticed in 4 (36.4%) S. aureus isolates (i.e.
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VISA strains), with no totally vancomycin-resistant (VRSA) strains.
All of phenotypic MRSA isolates, except of one, were positive for
PBP2a.
Conclusion: The study concludes that S. aureus is the most
prevalent pathogen causing bacteremia in leukemia patients, with
MRSA variety comprising the majority of these strains. Also, phe-
notypic method for MRSA detection can be performed using either
ofMethicillin, Oxacillin, or Cefoxitin with same results, with a non-
signiﬁcant statistical difference between the phenotypic method
and the genotypic method- via the PBP2a detection.
http://dx.doi.org/10.1016/j.ijid.2016.02.224
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Background: VancomycinResistant Enterococci (VRE) emerged
as one of the major nosocomial pathogen across the globe. Gut
colonisation rate with VRE is higher in patients admitted to ICUs
due to high antibiotic pressure. VRE colonisation increases the risk
of developing infection up to 5-10 folds. The aim of this study was
to determine the rates of VRE colonization among patients admit-
ted in two of the ICUs i.e. Medical Intensive Care Unit (MICU) and
Pediatric Intensive Care Unit (PICU) and to assess the various risk
factors which are associated with VRE colonization.
Methods & Materials: Rectal swabs were collected after
48hours of ICU admission from a total of 302 and 198 patients
from MICU and PICU respectively. Additionally samples were col-
lected every 48hours from 32 patients admitted in MICU and 19
patients in PICU whose initial VRE colonization was negative. The
samples were inoculated on to Bile Esculin Sodium azide Agar
(BEA) with 6mg/ml of vancomycin. Growth on this medium were
identiﬁed by standard biochemical test and Minimum Inhibitory
Concentration (MIC) of vancomycin and teicoplanin was detected
by Agar dilution method. Resistance genes for vancomycin were
detected by PCR. Risk factors were assessed by logistic regression
analysis. The patients were followed up to determine VRE infection
rates
Results: The rates of VRE colonization in patients admitted
to MICU was signiﬁcantly higher (29%) than those in PICU (19%).
Majority of the isolates were Enterococcus faecalis (62.6%) followed
by Enterococcus faecium (38.4%). All the VRE isolates were positive
for vanA gene. Younger age, increased duration of hospital stay,
consumption of ceftriaxone and vancomycin were found to be sig-
niﬁcantly associated with VRE colonization in MICU, while in PICU,
only vancomycin usage was the signiﬁcant risk factor. Among VRE
colonized patients, six (4.7%) acquired VRE infection.
Conclusion: The VRE colonization rates in our ICUs were com-
parable to other hospitals worldwide. Strict adherence to hand
hygiene and education of health care workers is necessary to min-
imize the nosocomial transmission of this organism.
http://dx.doi.org/10.1016/j.ijid.2016.02.225
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Background: As the use of colistin to treat carbapenem resis-
tant gram negative infections increases, colistin resistance is being
increasingly reported in Indian hospitals.
Methods & Materials: Retrospective chart review of clinical
data from patients with colistin resistant isolates (MIC>2). Clin-
ical proﬁle, outcome and antibiotic combinations that were used to
treat colistin resistant infection were analysed.
Results: Twenty four colistin resistant isolates were reported
over 18months (Jan 2014–June 2015). Themean age of the patients
was 58.33; average length of stay was 36.37 days. Previous hos-
pitalisation within 3 months was noted in all 24 patients. An
invasive device was used in 22(91.67%) patients. Urine was the
commonest site of infection=8(33%), followed by blood= 6(25%),
respiratory=5(20.8%), pus=4(16.67%) and other (CSF)=1(4.17%).
Commonest organism was Klebsiella, n =21(87.5%). Antibiotics
that were used in their current admission prior to isolating a
colistin resistant organismwere: colistin in 15 patients(62.5%), car-
bapenem in 19(79.17%), BL-BLI in 9(37.5%), tigecycline in 12(50%).
16(66.6%) were considered to have true infection while 8 (33.3%)
were considered as colonisation andwerenot treated. Sensitivity of
these isolates to other drugs tested were – tigecycline 18/24(75%),
chloramphenicol 15/24(62.5%), amikacin 7/24(29.17%), cotrimox-
azole 3/24(12.5%). Fosfomycin was tested in 4 isolates only and
was sensitive in all. Antibiotic that were used for treatment
were combinations of tigecycline, chloramphenicol, fosfomycin,
amikacin, ciproﬂoxacin, cotrimoxazole and sulbactam. Among 16
patients with true infection, 4(25%) improved, 9(56.25%) expired
and 3(18.75%) were transferred to other centers in poor condition
at patient’s request. Among 8 patients who were considered to
have colonisation, there were no deaths and 7(87.5%) improved.
Among the 6 bacteremic cases, 5 patients expired and 1 improved.
Among the non-bacteremic patientswith true infections 4/10(40%)
expired. Bacteremic patients had a signiﬁcantly higher risk of death
compared to all non-bacteremic patients (p =0.014) though not
signiﬁcantly in non-bacteremic infections after exclusion of col-
onization (p=0.145).
Conclusion: Colistin resistance among Gram negative bacteria,
especially Klebsiella, is emerging in Indian hospitals and carries a
